Timo Minssen

Professor

JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- timo.minssen@jur.ku.dk
- https://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631
Mobil: +46708607517

ORCID: 0000-0002-3286-4888

Udgivelsesår:

Alle

1 - 19 ud af 19Pr. side: 50

Sortering: 1. forfatter

Udgivet
Patentability Standards for Follow-on Pharmaceutical Innovation
Holman, C. M., Minssen, Timo & Solovy, E. M., 1 jun. 2018, I: Biotechnology Law Report. 37, 3, s. 131-161 31 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet
How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector
Kianzad, B. & Minssen, Timo, 2018, I: European Pharmaceutical Law Review. 2, 3, s. 133-148 16 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet
Challenges for the sustainability of university-run biobanks
Kongsholm, Nana Cecilie Halmsted, Christensen, Søren Tvorup, Herrmann, Janne Rothmar, Larsen, Lars Allan, Minssen, Timo, Pedersen, Lotte Bang, Rajam, N., Tommerup, Niels, Tupasela, A. M. & Schovsbo, Jens Hemmingsen, 2018, I: Biopreservation and Biobanking. 16, 4, s. 312-321 10 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet
A Ray of Light in Muddy Waters? -The CJEU rules on combination SPCs in C-121/17 Teva v Gilead
Minssen, Timo & Bostyn, Sven, 2018, I: European Pharmaceutical Law Review. 2, 3, s. 169-173 5 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet
FAIR DATA SHARING & DATA CARING IN THE DIGITALIZED ERA: ASPIRATIONS, REALITIES & LEGAL CLASHES IN THE HEALTH & LIFE SCIENCES: Abstract of presentation at Stanford Law School
Minssen, Timo, mar. 2018.
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › fagfællebedømt
Udgivet
Opportunities and challenges for user-generated licensing models in gene-editing
Minssen, Timo, Van Zimmeren, E. & Wested, Jakob, jul. 2018, Harvard Law School's Bill of Health blog.
Publikation: Andet › Udgivelser på nettet - Net-publikation › Formidling
Udgivet
Biosimilars- A European perspective
Minssen, Timo, 2018.
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › fagfællebedømt
Udgivet
Clearing a way through the CRISPR patent jungle
Minssen, Timo, Van Zimmeren, E. & Wested, Jakob, 2018, I: Life Sciences Intellectual Property Review (LSIPR). 8/5 2018, 4 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Udgivet
Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?
Minssen, Timo & Schovsbo, Jens Hemmingsen, jun. 2018, Intellectual Property and Digital Trade in the Age of Artificial Intelligence and Big Data. Seuba, X., Geiger, C. & Pénin, J. (red.). Centre d'études internationales de la propriété intellectuelles (CEIPI), s. 121-130 10 s. (CEIPI / ICTSD Publication Series on Global Perspectives and Challenges for the Intellectual Property System; Nr. 5).
Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Udgivet
Big Data and Intellectual Property Rights in the Health and Life Sciences
Minssen, Timo & Pierce, J., 2018, Big Data, Health Law, and Bioethics. Cohen, I. G., Fernandez Lynch, H., Vayena, E. & Gasser, U. (red.). Cambridge: Cambridge University Press, s. 311-323 13 s.
Publikation: Bidrag til bog/antologi/rapport › Konferencebidrag i proceedings › Forskning › fagfællebedømt
Udgivet
Unlocking the full potential of Open Innovation in the Life Sciences through a classification system
Nilsson, N. & Minssen, Timo, 1 apr. 2018, I: Drug Discovery Today. 23, 4, s. 771-775 5 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet
Response to Nuffield Council on Bioethics’ Genome editing and human reproduction: open call for evidence
Nordberg, A., Minssen, Timo, de Miguel Beriain, I., Wartiovaara, K., Galvagni, L. & Feeney, O., 1 jul. 2018, 2 s. Nuffield Council on Bioethics.
Publikation: Andet › Udgivelser på nettet - Net-publikation › Forskning › fagfællebedømt
Under udarbejdelse
Synthetic biology and the Law: tools and strategies for interdisciplinary research and education (in preparation)
Nordberg, A. & Minssen, Timo, 2018, (Under udarbejdelse).
Publikation: Working paper › Forskning › fagfællebedømt
Udgivet
Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concerns
Nordberg, A., Minssen, Timo, Holm, Sune Hannibal, Horst, M., Mortensen, Kell & Møller, Birger Lindberg, 2018, I: Journal of Law and the Biosciences . 5, 1, s. 35-83 49 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet
Reap what you sow! - But what about SPC squatting?
Schovsbo, Jens Hemmingsen, Klinge, Ulla Callesen & Minssen, Timo, 2018, I: Journal of Intellectual Property Law & Practice. 13, 7, s. 569-580 12 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Udgivet
AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities
Sherkow, J. S. & Minssen, Timo, 14 sep. 2018, Social Science Research Network (SSRN), 23 s.
Publikation: Working paper › Forskning
Udgivet
Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?
Wested, Jakob, Minssen, Timo & Van Zimmeren, E., jul. 2018, Harvard Law School's Bill of Health blog.
Publikation: Andet › Udgivelser på nettet - Net-publikation › Formidling
Udgivet
Research- & Bolar exemptions in the U.S. and Europe: Recent developments and possible scenarios: Report on CeBIL webinar III in the webinar series on "Reinterpreting TRIPS in the Life Sciences"
Wested, Jakob & Minssen, Timo, 15 jul. 2018, Social Science Research Network (SSRN). 11 s.
Publikation: Bog/antologi/afhandling/rapport › Rapport › Forskning
Udgivet
Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
Wested, Jakob, Minssen, Timo & Van Zimmeren, E., 13 jul. 2018, I: Life Sciences Intellectual Property Review (LSIPR). 13/7 2018, 6 s.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

ID: 16150437

Det Juridiske Fakultet

Timo Minssen

JUR Center for Advanced Studies in Bioscience Innovation Law

Patentability Standards for Follow-on Pharmaceutical Innovation

How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector

Challenges for the sustainability of university-run biobanks

A Ray of Light in Muddy Waters? -The CJEU rules on combination SPCs in C-121/17 Teva v Gilead

FAIR DATA SHARING & DATA CARING IN THE DIGITALIZED ERA: ASPIRATIONS, REALITIES & LEGAL CLASHES IN THE HEALTH & LIFE SCIENCES: Abstract of presentation at Stanford Law School

Opportunities and challenges for user-generated licensing models in gene-editing

Biosimilars- A European perspective

Clearing a way through the CRISPR patent jungle

Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?

Big Data and Intellectual Property Rights in the Health and Life Sciences

Unlocking the full potential of Open Innovation in the Life Sciences through a classification system

Response to Nuffield Council on Bioethics’ Genome editing and human reproduction: open call for evidence

Synthetic biology and the Law: tools and strategies for interdisciplinary research and education (in preparation)

Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concerns

Reap what you sow! - But what about SPC squatting?

AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities

Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?

Research- & Bolar exemptions in the U.S. and Europe: Recent developments and possible scenarios: Report on CeBIL webinar III in the webinar series on "Reinterpreting TRIPS in the Life Sciences"

Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?

Flest downloads

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa

The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa